GlassScriptPhysician profile
Steven Kester
NPI 1033265723
$4,772.05
in general payments reported to CMS, 2019-2025
55 companies · $829 in 2025
The $829 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $582 · 2020: $397 · 2021: $685 · 2022: $770 · 2023: $577 · 2024: $932 · 2025: $829.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,314 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $24.11.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,313.64 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $24.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $444.27 | 2019-2022 | |
| Verity Pharmaceuticals INC. | $315.01 | 2024-2025 | Tlando, Trelstar |
| Coloplast Corp | $280.28 | 2020-2025 | Speedicath |
| Medical Device Business Services, INC. | $263.53 | 2019-2024 | |
| Csl Behring | $248.19 | 2020-2025 | Kcentra |
| Astellas Pharma US INC | $225.33 | 2019-2022 | |
| Myriad Genetic Laboratories, INC. | $185.54 | 2021-2023 | Prolaris |
| Stryker Corporation | $166.63 | 2022 | |
| Atricure, INC. | $165.83 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $158.50 | 2022-2025 | Lynparza |
| Cumberland Pharmaceuticals, INC. | $149.11 | 2023 | Caldolor |
| Terumo Medical Corporation | $142.42 | 2022 | |
| Davol INC. | $141.32 | 2024 | Phasix Mesh |
| Olympus America INC. | $135.24 | 2021-2024 | Itind System |
| Eagle Pharmaceuticals, INC. | $127.51 | 2024 |
Show all 46 companies
9 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Kester listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.